Review Article
Published On:
April 17, 2018
Chen JQ, Wang F, Chen X, Zhang Y and Liu HX*
Because of the majority of tumor therapeutic drugs with more adverse reaction, narrow treatment window, and significant individual differences, the correct and rational application of anti-tumor drugs will help to reduce mortality, relapse rate and incidence of adverse drug reactions of patients with malignancies. With the progress of Pharmacogenomics research...